Do 8‑inch bed risers help patients with obstructive sleep apnea?

8-Inch Bed Risers Do Not Help Patients with Sleep Apnea

No, 8-inch bed risers are not recommended for treating obstructive sleep apnea. While head-of-bed elevation (HOBE) shows some physiological benefit, the evidence demonstrates it is clearly inferior to CPAP therapy, has poor long-term compliance, and should not be used except in very carefully selected patients 1.

Why Bed Elevation Falls Short

The European Respiratory Society guideline explicitly states that positional therapy (including head elevation) is clearly inferior to CPAP and long-term compliance is poor 1. The evidence shows:

• Moderate reductions in AHI at best: Even when positional therapy works, it yields only moderate improvements in breathing parameters 1
• Poor adherence: Only 29% of patients continued using positional devices after 2 years 1
• Limited patient selection: Benefits are primarily seen in younger patients with lower AHI scores and less obesity 1

What Recent Research Actually Shows

While newer studies (2022-2025) demonstrate that 30-degree head-of-bed elevation can reduce AHI by approximately 31% 2, 3, these findings don't change the fundamental recommendation. Here's the critical nuance:

The research shows physiological improvement but not clinical superiority. Studies found:

• AHI decreased from 25.7 to 17.8 events/hour with 30° elevation 2
• Only 50% of OSA patients achieved "responder status" (≥50% AHI reduction) 2
• Sleep efficiency improved, but many patients remained in moderate OSA range despite elevation 4, 3

The Evidence-Based Treatment Hierarchy

The American College of Physicians guideline provides clear direction 5:

1. First-line: CPAP therapy - Strong recommendation for moderate-to-severe OSA (Grade A) 5
2. Alternative: Mandibular advancement devices - For patients who prefer them or have CPAP adverse effects (Grade B-C) 5
3. Adjunctive: Weight loss - Recommended for all obese patients (Grade A) 1

Positional therapy receives only a Grade C recommendation and only for "carefully selected patients" 1.

Common Pitfalls to Avoid

• Don't confuse 8-inch risers with 30-degree elevation: Most research uses 30° (approximately 7.5 degrees), not the steeper angle created by 8-inch risers under standard bed legs
• Don't use this as monotherapy: Even when considering HOBE, it should not replace proven therapies 1
• Don't assume symptom improvement equals adequate treatment: Patients may feel somewhat better but remain at cardiovascular risk with inadequately treated OSA

When HOBE Might Be Considered

The 2021 European Respiratory Society guideline suggests HOBE only as a non-CPAP alternative for selected positional OSA phenotypes 6. Specifically consider it for:

• Younger patients with mild OSA (AHI 10-15)
• Non-obese individuals with clear positional component
• Patients who absolutely refuse or cannot tolerate CPAP
• Always with follow-up sleep studies to document efficacy 1

The Bottom Line for Clinical Practice

Recommend CPAP as first-line therapy 5. If the patient refuses CPAP, consider mandibular advancement devices before positional therapy 5. If you do trial head-of-bed elevation, use 30-degree elevation (not 8-inch risers), perform follow-up polysomnography to document response, and monitor long-term compliance closely 1, 2.

The cardiovascular and mortality benefits of CPAP are well-established 1, while positional therapy lacks this evidence base. Don't let patients substitute an unproven intervention for effective treatment that reduces morbidity and mortality.